Clinical Trial Update: THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial at UCLA is evaluating THC and CBD as a harm reduction strategy for individuals with drug abuse and pain; the study is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain
• Substance Use Disorder

Drugs mentioned

• Cannabidiol (cannabidiol)
• Tetrahydrocannabinol (delta-9-tetrahydrocannabinol)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Abuse, Drug, Pain | Phase 1 | Status: RECRUITING